Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2026-10-09
Passage BIO, Inc.
CIK 1787297
 EFFECTDeclared effective9999999995-26-003198
2025-03-05
Passage BIO, Inc.
ShelfEffectiveCIK 1787297
 424B5Shelf takedown0001104659-25-020562
2024-04-16
Passage BIO, Inc.
ShelfEffectiveCIK 1787297
 EFFECTDeclared effective9999999995-24-000982
2024-03-04
Passage BIO, Inc.
ShelfEffectiveCIK 1787297
 S-3Shelf registered0001104659-24-030481
2022-04-14
Passage BIO, Inc.
ShelfEffectiveCIK 1787297
 EFFECTDeclared effective9999999995-22-000975
2021-03-05
Passage BIO, Inc.
ShelfEffectiveCIK 1787297
 S-3ASRShelf registered0001104659-21-032832
2021-01-22
Passage BIO, Inc.
Registered companyFinal prospectusCIK 1787297
 424B1Final prospectus0001104659-21-006683
2021-01-21
Passage BIO, Inc.
Registered companyFinal prospectusCIK 1787297
 EFFECTDeclared effective9999999995-21-000233
2021-01-19
Passage BIO, Inc.
Registered companyFinal prospectusCIK 1787297
 S-1Registration filed0001104659-21-005296
2020-12-18
Passage BIO, Inc.
CIK 1787297
 DRSDraft made public0001104659-20-137415
2020-02-28
Passage BIO, Inc.
IPOFinal prospectusCIK 1787297
 424B4Final prospectus0001047469-20-001117
2020-02-27
Passage BIO, Inc.
IPOFinal prospectusCIK 1787297
 EFFECTDeclared effective9999999995-20-000432
2020-02-27
Passage BIO, Inc.
IPOFinal prospectusCIK 1787297
 S-1/AAmendment0001047469-20-001071
2020-02-18
Passage BIO, Inc.
IPOFinal prospectusCIK 1787297
 S-1/AAmendment0001047469-20-000894
2020-02-03
Passage BIO, Inc.
IPOFinal prospectusCIK 1787297
 S-1Registration filed0001047469-20-000652
2019-12-06
Passage BIO, Inc.
CIK 1787297
 DRSDraft made public0000912057-19-000450